Koers CannTrust Holdings Inc Canadian Securities Exchange
Aandelen
TRST
CA1378002077
Farmaceutische producten
Omzet 2017 | 20,7 28,32 19,23 | Omzet 2018 | 45,65 62,46 42,42 | Marktkapitalisatie | 508 mln. 695 mln. 472 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | 6 mln. 8,21 mln. 5,58 mln. | Nettowinst (verlies) 2018 | -13 mln. -17,79 mln. -12,08 mln. | EV/omzet 2017 | 31.215.427 x |
Nettoliquiditeiten 2017 | 17,16 mln. 23,49 mln. 15,95 mln. | Nettoliquiditeiten 2018 | 58 mln. 79,36 mln. 53,9 mln. | EV/omzet 2018 | 9.864.003 x |
K/w-verhouding 2017 |
81,5
x | K/w-verhouding 2018 |
-34,5
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-19 |
David Blair
DFI | Director of Finance/CFO | - | 01-10-19 |
Sales & Marketing | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-19 |
Dan Hogan
BRD | Director/Board Member | - | 17-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,19 mld. | |
+3,98% | 3,15 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |